Toth Financial Advisory’s AstraZeneca AZN Stock Holding History

Toth Financial Advisory’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.02K	Hold	37	–	–	﹤0.01%	619
2026 Q1	$7.3K	Buy	37 +28	+311%	+$5.4K	﹤0.01%	597
2025 Q4	$1.66K	Buy	+9	New	+$1.58K	﹤0.01%	735

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Toth Financial Advisory's AZN Position: Q2 2026 in Review

Toth Financial Advisory held its AstraZeneca (AZN) position steady in Q2 2026 at 37 shares worth $7.02K. The position accounts for ﹤0.01% of the portfolio, ranked #619.

Toth Financial Advisory first reported a position in AZN in Q4 2025 and has held it in 3 quarters since. The position peaked at $7.3K in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Toth Financial Advisory held 37 shares of AstraZeneca worth $7.02K as of Q2 2026.
Toth Financial Advisory left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up ﹤0.01% of Toth Financial Advisory's portfolio in Q2 2026, its #619 holding.
Toth Financial Advisory first reported a position in AstraZeneca in Q4 2025 and has held it in 3 quarters since.
Toth Financial Advisory's AstraZeneca position peaked at $7.3K in Q1 2026.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.